Fingerprint
Dive into the research topics of 'Use, variability, and justification of eligibility criteria for phase II and III clinical trials in acute leukemia'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Use, variability, and justification of eligibility criteria for phase II and III clinical trials in acute leukemia
Andrew Hantel*, Marlise R. Luskin, Irum Khan, Elizabeth Warner, Anand A. Patel, Thomas P. Walsh, Daniel J. DeAngelo, Christopher S. Lathan, Gregory A. Abel
*Corresponding author for this work
Research output: Contribution to journal › Article › peer-review
7
Scopus
citations